Evidence map›Paper›PMID 38148420›Full record

ArticleParasitology research2023

Effects of the probiotic Bacillus cereus GM on experimental schistosomiasis mansoni.

Victor Hugo Barbosa Dos Santos, Eulália Camelo Pessoa de Azevedo Ximenes, Renan Andrade Fernandes de Souza, Raul Penaforte Correia da Silva, Maria da Conceição Silva, Lucas Vinícius Moreira de Andrade, Valdenia Maria de Souza Oliveira, Mario Ribeiro de Melo-Júnior, Vlaudia Maria Assis Costa, Virginia Maria de Barros Lorena and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Mechanistic insights intoJournal of advanced veterinary and animal research · 2025
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Victor Hugo Barbosa Dos SantosInstituto Keizo Asami (iLIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil.
Eulália Camelo Pessoa de Azevedo XimenesPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade Federal de Pernambuco, Recife, PE, Brazil.
Renan Andrade Fernandes de SouzaInstituto Keizo Asami (iLIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil.
Raul Penaforte Correia da SilvaInstituto Keizo Asami (iLIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil.
Maria da Conceição SilvaInstituto Keizo Asami (iLIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil.
Lucas Vinícius Moreira de AndradeInstituto Keizo Asami (iLIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil.
Valdenia Maria de Souza OliveiraInstituto Keizo Asami (iLIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil.
Mario Ribeiro de Melo-JúniorDepartamento de Patologia, Universidade Federal de Pernambuco, Recife, PE, Brazil.
Vlaudia Maria Assis CostaInstituto Keizo Asami (iLIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil.
Virginia Maria de Barros LorenaInstituto Aggeu Magalhães, Laboratório de Imunologia, Fundação Oswaldo Cruz, Recife, PE, Brazil.
Hallysson Douglas Andrade de AraújoInstituto Keizo Asami (iLIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil.
André de Lima AiresInstituto Keizo Asami (iLIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil.
Mônica Camelo Pessoa de Azevedo AlbuquerqueInstituto Keizo Asami (iLIKA), Universidade Federal de Pernambuco, Recife, PE, Brazil. monica.aalbuquerque@ufpe.br.
Universidade Federal de Pernambuco · BRFundação Oswaldo Cruz · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Probiotics contribute to the integrity of the intestinal mucosa and preventing dysbiosis caused by opportunistic pathogens, such as intestinal helminths. Bacillus cereus GM obtained from Biovicerin® was cultured to obtain spores for in vivo evaluation on experimental schistosomiasis. The assay was performed for 90 days, where all animals were infected with 50 cercariae of Schistosoma mansoni on the 15th day. Three experimental groups were formed, as follows: G1-saline solution from the 1st until the 90th day; G2-B. cereus GM (10

Indexed as

ProbioticsSchistosomiasisSchistosomiasis mansoniAnimalsBacillus cereusFemaleLiverMiceSchistosoma mansoniBacillus cereusImmunomodulationProbioticSchistosoma mansoniSchistosomiasis

Identifiers

PMID38148420
OpenAlexW4390244956

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.